Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis

June 2009

Reps will be promoting Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis.

It's an alternative to Enbrel, Humira, or Remicade for rheumatoid and other forms of inflammatory arthritis.

There's no proof that any TNF blocker is more effective than another for improving symptoms and slowing progression.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote